tradingkey.logo
搜索

Crescent Biopharma Ord Shs

CBIO
添加自选
14.150USD
-0.220-1.53%
收盘 11-13 16:00(美东)
525.53M总市值
亏损市盈率 TTM

关于 Crescent Biopharma Ord Shs 公司

Crescent Biopharma, Inc. is a biotechnology company. The Company is focused on advancing the next wave of therapies for cancer patients. The Company’s pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. The Company’s lead program is CR-001, a tetravalent PD-1 x VEGF bispecific antibody in development for the treatment of solid tumors, and it is also advancing CR-002 and CR-003, antibody drug conjugates (ADCs) with topoisomerase inhibitor payloads. CR-002 and CR-003 are ADCs designed to deliver clinically active cytotoxic drugs known as topoisomerase inhibitors to tumor cells. Each of these programs has the potential to deliver therapeutics with clinical efficacy both as a monotherapy and in combination with CR-001 with significant potential across solid tumor indications.

Crescent Biopharma Ord Shs 简介

公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -

Crescent Biopharma Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Dr. Ellie Eunkyung Im
Dr. Ellie Eunkyung Im
Chief Medical Officer
Chief Medical Officer
112.00
-1088.39%
Dr. Ellie Eunkyung Im
Dr. Ellie Eunkyung Im
Chief Medical Officer
Chief Medical Officer
112.00
-1088.39%
Dr. Ellie Eunkyung Im
Dr. Ellie Eunkyung Im
Chief Medical Officer
Chief Medical Officer
112.00
-1088.39%
Dr. Susan M. Moran, M.D.
Dr. Susan M. Moran, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%

常见问题

Crescent Biopharma Ord Shs的前五大股东是谁?

Crescent Biopharma Ord Shs 的前五大股东如下:Dr. Jonathan Violin, Ph.D.
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有